1![Biotin (Cerenday) for permanent disability related to multiple sclerosis relapses – add on therapy to current immunomodulators Biotin (Cerenday) for permanent disability related to multiple sclerosis relapses – add on therapy to current immunomodulators](https://www.pdfsearch.io/img/a80bfe13f26c4cac5431c4c3ac68a4e9.jpg) | Add to Reading ListSource URL: www.hsc.nihr.ac.ukLanguage: English |
---|
2![Microsoft Word[removed]abiraterone ZYTIGA JANSSEN PSD[removed]FINAL.doc Microsoft Word[removed]abiraterone ZYTIGA JANSSEN PSD[removed]FINAL.doc](https://www.pdfsearch.io/img/c3df4a7e0e103c115244404b9f7db6c2.jpg) | Add to Reading ListSource URL: www.pbs.gov.auLanguage: English - Date: 2014-10-01 21:56:22
|
---|
3![PUBLIC SUMMARY DOCUMENT Product: Abiraterone, tablet, 250 mg (as acetate), Zytiga® Sponsor: Janssen-Cilag Pty Ltd Date of PBAC Consideration: November[removed]Purpose of Application PUBLIC SUMMARY DOCUMENT Product: Abiraterone, tablet, 250 mg (as acetate), Zytiga® Sponsor: Janssen-Cilag Pty Ltd Date of PBAC Consideration: November[removed]Purpose of Application](https://www.pdfsearch.io/img/a92665d4cb81a2f0920a4d26657415cb.jpg) | Add to Reading ListSource URL: www.pbs.gov.auLanguage: English - Date: 2014-11-10 21:39:36
|
---|
4![Microsoft Word - Abiraterone ZYTIGA Janssen Cilag PSD[removed]FINAL.doc Microsoft Word - Abiraterone ZYTIGA Janssen Cilag PSD[removed]FINAL.doc](https://www.pdfsearch.io/img/d0d74297b1e1d581803e57e523d70f32.jpg) | Add to Reading ListSource URL: www.pbs.gov.auLanguage: English - Date: 2014-10-01 21:56:21
|
---|
5![Deciding on Motherhood For Women Living with MS FreecallTM[removed]www.msaustralia.org.au Deciding on Motherhood For Women Living with MS FreecallTM[removed]www.msaustralia.org.au](https://www.pdfsearch.io/img/5bfede63eb05926a5c7f6fc0ca2bde8c.jpg) | Add to Reading ListSource URL: www.mssociety.org.auLanguage: English - Date: 2012-08-27 22:12:46
|
---|
6![ORIGINAL CONTRIBUTION High-Dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis Douglas E. Gladstone, MD; Kenneth W. Zamkoff, MD; Lauren Krupp, MD; Robert Peyster, MD; Patrick Sibony, MD; Christoph ORIGINAL CONTRIBUTION High-Dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis Douglas E. Gladstone, MD; Kenneth W. Zamkoff, MD; Lauren Krupp, MD; Robert Peyster, MD; Patrick Sibony, MD; Christoph](https://www.pdfsearch.io/img/8e8c4967a4156c4f3e1522385110edc1.jpg) | Add to Reading ListSource URL: www.direct-ms.orgLanguage: English - Date: 2010-12-22 01:50:32
|
---|
7![Questions
to
Ask
Your
Doctor
–
Chemotherapy
Questions to Ask Your Doctor Chemotherapy All the test results are in and so is the diagnosis: prostate cancer. What Questions
to
Ask
Your
Doctor
–
Chemotherapy
Questions to Ask Your Doctor Chemotherapy All the test results are in and so is the diagnosis: prostate cancer. What](https://www.pdfsearch.io/img/09409d2cb4de505747e60fc50cb80bd3.jpg) | Add to Reading ListSource URL: www.prostate.netLanguage: English - Date: 2013-09-11 06:51:22
|
---|
8![Issue 14 l[removed]l Disease courses in MS MSIF14 pp01 cover.indd 1 Issue 14 l[removed]l Disease courses in MS MSIF14 pp01 cover.indd 1](https://www.pdfsearch.io/img/debfb2520915b3ba0c2f4cf4db31a590.jpg) | Add to Reading ListSource URL: www.msif.orgLanguage: English - Date: 2014-10-14 05:17:55
|
---|
9![July 2014
DISCLOSURES Writing and Development Team Kathleen Costello, MS, ANP – Nothing to disclose June Halper, MSN, APN-C – Consultant (CME): Biogen Idec July 2014
DISCLOSURES Writing and Development Team Kathleen Costello, MS, ANP – Nothing to disclose June Halper, MSN, APN-C – Consultant (CME): Biogen Idec](https://www.pdfsearch.io/img/33720909385ee7823d0cb67809593eb5.jpg) | Add to Reading ListSource URL: www.nationalmssociety.orgLanguage: English - Date: 2014-09-23 13:57:08
|
---|
10![Oncologic Drugs Advisory Committee Meeting Briefing Document Pixantrone dimaleate (BBR[removed]Injection for the treatment of patients with relapsed or refractory aggressive Non-Hodgkin’s Lymphoma who have received 2 or Oncologic Drugs Advisory Committee Meeting Briefing Document Pixantrone dimaleate (BBR[removed]Injection for the treatment of patients with relapsed or refractory aggressive Non-Hodgkin’s Lymphoma who have received 2 or](https://www.pdfsearch.io/img/552d60ec7599393b8d6eed20a1ff4d99.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|